Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

131.26
Delayed Data
As of Aug 16
 -0.11 / -0.08%
Today’s Change
96.93
Today|||52-Week Range
139.00
+13.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues2.9B3.0B2.9B3.2B
 
 
 
 
 
Cost of Goods Sold75.0M80.3M79.0M76.0M
 
 
 
 
 
Depreciation And Amortization119.8M138.5M116.0M123.0M
 
 
 
 
 
 
Operating ExpensesGross Income2.7B2.8B2.7B3.0B
 
 
 
 
 
General Expenses2.4B1.8B1.6B1.8B
 
 
 
 
 
Research And Development1.7B1.1B995.0M835.0M
 
 
 
 
 
Total Operating Expenses2.5B2.0B1.8B2.0B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income365.5M942.4M1.1B1.2B
 
 
 
 
 
Extraordinary Credit----6.0M13.0M
 
 
 
Extraordinary Charge-72.9M-12.5M-42.0M-88.0M
 
 
 
 
 
Interest Expense On Debt135.6M127.1M134.0M124.0M
 
 
 
 
 
Other Expenses61.8M-312.8M116.0M91.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income256.8M499.0M1.0B1.1B
 
 
 
 
 
Income Taxes-85.4M-70.1M-84.0M-69.0M
 
 
 
 
 
Net Income171.4M428.9M941.0M1.1B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS775.8M776.8M779.0M780.4M
 
 
 
 
 
Shares To Calculate EPS Diluted801.5M802.2M811.2M811.7M
 
 
 
 
 
 
Earnings Per ShareEPS$0.21$0.53$1.16$1.31
 
 
 
 
 
EPS Diluted$0.21$0.53$1.16$1.31